Skip To Main Content
Jordy Schol on Muck Rack

Jordy Schol

  • Spine Researcher
Japan, Kanagawa
As seen in: Color Research & Application, Nature, MDPI, Future Medicine
Regenerative medicine spine researcher. Expat in Japan. Following global-politics. Thinks Green is the solution! 🇪🇺 #iameuropean

Get in touch with Jordy

Contact Jordy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jordy Schol’s Journalist Portfolio

Enter your email address below. If your address has been previously registered, you will receive an email wit…

View article →

Enter your email address below. If your address has been previously registered, you will receive an email wit…

View article →
Cell therapy for intervertebral disc repair: Clinical perspective

Cell therapy for intervertebral disc repair: Clinical perspective

Low back pain is the main cause of disability and is associated with intervertebral disc degeneration. Contem…

View article →
Regenerative technologies to bed side: Evolving the regulatory framework

Regenerative technologies to bed side: Evolving the regulatory framework

There are high expectations for the clinical application of regenerative medicine technologies to treat muscu…

View article →
Biological Approaches to Spinal Disc Repair and Regeneration for Clinicians

Biological Approaches to Spinal Disc Repair and Regeneration for Clinicians

Although there have been significant advancements in minimally invasive spinal surgery techniques in the last…

View article →

View article →

Articles

Tie2-enriched nucleus pulposus cell transplantation enables severity-independent disc repair in a canine model with induced and controlled disc degeneration severity

|
By Jordy Schol, Takayuki Warita, Shota Tamagawa, Shota Ogasawara, Takafumi Konishi, Masato Sato, Masahiko Watanabe, Daisuke Sakai, Erika Matsushita, Takano Susumu, Asami Kawachi
| Nature Verified
Abstract Intervertebral disc (IVD) degeneration is characterized by extracellular matrix loss, impaired nucleus pulposus cell (NPC) function, and depletion of Tie2-positive NP progenitor cells, leading to progressive structural failure and potential pain. Although cell-based therapies are promising, their regenerative efficacy across different degeneration severities remains unclear.
Open in Who Shared Issue with article?

Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration

|
By Shota Ogasawara, Jordy Schol, Daisuke Sakai, Takayuki Warita
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters

|
By Jordy Schol, Daisuke Sakai, Yoshihiko Nakamura, Yuto Otani
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 8 articles